Integra Therapeutics

Active#49 in Spain

Gene writing

Biotech›gene writing

HQBarcelona

RaisedEUR 10.7M+

Last roundPre-Series A · 2025

Country of originSpainListed in the Spain ranking

Where would you invest?SpainJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Spain · all sectors	Top 50	#49	Edition 0 – beta · October 2026	3 Nov 2026

Rank historyOct 2026 · #49First edition: no movements yet.

Estimated valuation

AI · Spain ranking

≈ USD 62MUSD 31–120M · Tens of M$ Low confidence

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Pre-Series A · USD 12M · 2025
AI adjustment: None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

EUR 10.7M+ raised in total

Date	Round	Amount	Type	Investors
2025	Pre-Series A	USD 12M (EUR 10.7M)	Equity	EIC Fund, CDTI, Takeda Ventures

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Integra Therapeutics as a PDF, on one of three angles only:

ValuationWhat is Integra Therapeutics worth?

Versus competitorsIs #49 the right rank?

Who should acquire itStrategic buyers, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back Integra Therapeutics whether or not it has agreed: your intention joins the pool on Integra Therapeutics, passed to the local partner once it reaches critical mass. Declaring an intention does not mean this company is raising funds.

Back Integra Therapeutics Or back biotech in Spain

Pool on Integra TherapeuticsBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Integra Therapeutics?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Spain

Full Spain ranking →

SpliceBio#11Biotech › gene therapy (ophthalmology)Hundreds of M$Ona Therapeutics#14Biotech › antibody-drug conjugates (oncology)Hundreds of M$Telum Therapeutics#40Biotech › antimicrobialsHundreds of M$Nanoligent#48Biotech › targeted cancer nanomedicinesTens of M$

Investors in Integra Therapeutics: EIC Fund · CDTI · Takeda Ventures

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.